table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Cancer Gene Therapy Market Size Analysis from 2023 to 2028
1.5.1 Global Cancer Gene Therapy Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Cancer Gene Therapy Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Cancer Gene Therapy Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Cancer Gene Therapy Industry Impact
Chapter 2 Global Cancer Gene Therapy Competition by Types, Applications, and Top Regions and Countries
2.1 Global Cancer Gene Therapy (Volume and Value) by Type
2.1.1 Global Cancer Gene Therapy Consumption and Market Share by Type (2017-2022)
2.1.2 Global Cancer Gene Therapy Revenue and Market Share by Type (2017-2022)
2.2 Global Cancer Gene Therapy (Volume and Value) by Application
2.2.1 Global Cancer Gene Therapy Consumption and Market Share by Application (2017-2022)
2.2.2 Global Cancer Gene Therapy Revenue and Market Share by Application (2017-2022)
2.3 Global Cancer Gene Therapy (Volume and Value) by Regions
2.3.1 Global Cancer Gene Therapy Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Cancer Gene Therapy Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Cancer Gene Therapy Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Cancer Gene Therapy Consumption by Regions (2017-2022)
4.2 North America Cancer Gene Therapy Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Cancer Gene Therapy Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Cancer Gene Therapy Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Cancer Gene Therapy Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Cancer Gene Therapy Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Cancer Gene Therapy Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Cancer Gene Therapy Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Cancer Gene Therapy Sales, Consumption, Export, Import (2017-2022)
4.10 South America Cancer Gene Therapy Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Cancer Gene Therapy Market Analysis
5.1 North America Cancer Gene Therapy Consumption and Value Analysis
5.1.1 North America Cancer Gene Therapy Market Under COVID-19
5.2 North America Cancer Gene Therapy Consumption Volume by Types
5.3 North America Cancer Gene Therapy Consumption Structure by Application
5.4 North America Cancer Gene Therapy Consumption by Top Countries
5.4.1 United States Cancer Gene Therapy Consumption Volume from 2017 to 2022
5.4.2 Canada Cancer Gene Therapy Consumption Volume from 2017 to 2022
5.4.3 Mexico Cancer Gene Therapy Consumption Volume from 2017 to 2022
Chapter 6 East Asia Cancer Gene Therapy Market Analysis
6.1 East Asia Cancer Gene Therapy Consumption and Value Analysis
6.1.1 East Asia Cancer Gene Therapy Market Under COVID-19
6.2 East Asia Cancer Gene Therapy Consumption Volume by Types
6.3 East Asia Cancer Gene Therapy Consumption Structure by Application
6.4 East Asia Cancer Gene Therapy Consumption by Top Countries
6.4.1 China Cancer Gene Therapy Consumption Volume from 2017 to 2022
6.4.2 Japan Cancer Gene Therapy Consumption Volume from 2017 to 2022
6.4.3 South Korea Cancer Gene Therapy Consumption Volume from 2017 to 2022
Chapter 7 Europe Cancer Gene Therapy Market Analysis
7.1 Europe Cancer Gene Therapy Consumption and Value Analysis
7.1.1 Europe Cancer Gene Therapy Market Under COVID-19
7.2 Europe Cancer Gene Therapy Consumption Volume by Types
7.3 Europe Cancer Gene Therapy Consumption Structure by Application
7.4 Europe Cancer Gene Therapy Consumption by Top Countries
7.4.1 Germany Cancer Gene Therapy Consumption Volume from 2017 to 2022
7.4.2 UK Cancer Gene Therapy Consumption Volume from 2017 to 2022
7.4.3 France Cancer Gene Therapy Consumption Volume from 2017 to 2022
7.4.4 Italy Cancer Gene Therapy Consumption Volume from 2017 to 2022
7.4.5 Russia Cancer Gene Therapy Consumption Volume from 2017 to 2022
7.4.6 Spain Cancer Gene Therapy Consumption Volume from 2017 to 2022
7.4.7 Netherlands Cancer Gene Therapy Consumption Volume from 2017 to 2022
7.4.8 Switzerland Cancer Gene Therapy Consumption Volume from 2017 to 2022
7.4.9 Poland Cancer Gene Therapy Consumption Volume from 2017 to 2022
Chapter 8 South Asia Cancer Gene Therapy Market Analysis
8.1 South Asia Cancer Gene Therapy Consumption and Value Analysis
8.1.1 South Asia Cancer Gene Therapy Market Under COVID-19
8.2 South Asia Cancer Gene Therapy Consumption Volume by Types
8.3 South Asia Cancer Gene Therapy Consumption Structure by Application
8.4 South Asia Cancer Gene Therapy Consumption by Top Countries
8.4.1 India Cancer Gene Therapy Consumption Volume from 2017 to 2022
8.4.2 Pakistan Cancer Gene Therapy Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Cancer Gene Therapy Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Cancer Gene Therapy Market Analysis
9.1 Southeast Asia Cancer Gene Therapy Consumption and Value Analysis
9.1.1 Southeast Asia Cancer Gene Therapy Market Under COVID-19
9.2 Southeast Asia Cancer Gene Therapy Consumption Volume by Types
9.3 Southeast Asia Cancer Gene Therapy Consumption Structure by Application
9.4 Southeast Asia Cancer Gene Therapy Consumption by Top Countries
9.4.1 Indonesia Cancer Gene Therapy Consumption Volume from 2017 to 2022
9.4.2 Thailand Cancer Gene Therapy Consumption Volume from 2017 to 2022
9.4.3 Singapore Cancer Gene Therapy Consumption Volume from 2017 to 2022
9.4.4 Malaysia Cancer Gene Therapy Consumption Volume from 2017 to 2022
9.4.5 Philippines Cancer Gene Therapy Consumption Volume from 2017 to 2022
9.4.6 Vietnam Cancer Gene Therapy Consumption Volume from 2017 to 2022
9.4.7 Myanmar Cancer Gene Therapy Consumption Volume from 2017 to 2022
Chapter 10 Middle East Cancer Gene Therapy Market Analysis
10.1 Middle East Cancer Gene Therapy Consumption and Value Analysis
10.1.1 Middle East Cancer Gene Therapy Market Under COVID-19
10.2 Middle East Cancer Gene Therapy Consumption Volume by Types
10.3 Middle East Cancer Gene Therapy Consumption Structure by Application
10.4 Middle East Cancer Gene Therapy Consumption by Top Countries
10.4.1 Turkey Cancer Gene Therapy Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Cancer Gene Therapy Consumption Volume from 2017 to 2022
10.4.3 Iran Cancer Gene Therapy Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Cancer Gene Therapy Consumption Volume from 2017 to 2022
10.4.5 Israel Cancer Gene Therapy Consumption Volume from 2017 to 2022
10.4.6 Iraq Cancer Gene Therapy Consumption Volume from 2017 to 2022
10.4.7 Qatar Cancer Gene Therapy Consumption Volume from 2017 to 2022
10.4.8 Kuwait Cancer Gene Therapy Consumption Volume from 2017 to 2022
10.4.9 Oman Cancer Gene Therapy Consumption Volume from 2017 to 2022
Chapter 11 Africa Cancer Gene Therapy Market Analysis
11.1 Africa Cancer Gene Therapy Consumption and Value Analysis
11.1.1 Africa Cancer Gene Therapy Market Under COVID-19
11.2 Africa Cancer Gene Therapy Consumption Volume by Types
11.3 Africa Cancer Gene Therapy Consumption Structure by Application
11.4 Africa Cancer Gene Therapy Consumption by Top Countries
11.4.1 Nigeria Cancer Gene Therapy Consumption Volume from 2017 to 2022
11.4.2 South Africa Cancer Gene Therapy Consumption Volume from 2017 to 2022
11.4.3 Egypt Cancer Gene Therapy Consumption Volume from 2017 to 2022
11.4.4 Algeria Cancer Gene Therapy Consumption Volume from 2017 to 2022
11.4.5 Morocco Cancer Gene Therapy Consumption Volume from 2017 to 2022
Chapter 12 Oceania Cancer Gene Therapy Market Analysis
12.1 Oceania Cancer Gene Therapy Consumption and Value Analysis
12.2 Oceania Cancer Gene Therapy Consumption Volume by Types
12.3 Oceania Cancer Gene Therapy Consumption Structure by Application
12.4 Oceania Cancer Gene Therapy Consumption by Top Countries
12.4.1 Australia Cancer Gene Therapy Consumption Volume from 2017 to 2022
12.4.2 New Zealand Cancer Gene Therapy Consumption Volume from 2017 to 2022
Chapter 13 South America Cancer Gene Therapy Market Analysis
13.1 South America Cancer Gene Therapy Consumption and Value Analysis
13.1.1 South America Cancer Gene Therapy Market Under COVID-19
13.2 South America Cancer Gene Therapy Consumption Volume by Types
13.3 South America Cancer Gene Therapy Consumption Structure by Application
13.4 South America Cancer Gene Therapy Consumption Volume by Major Countries
13.4.1 Brazil Cancer Gene Therapy Consumption Volume from 2017 to 2022
13.4.2 Argentina Cancer Gene Therapy Consumption Volume from 2017 to 2022
13.4.3 Columbia Cancer Gene Therapy Consumption Volume from 2017 to 2022
13.4.4 Chile Cancer Gene Therapy Consumption Volume from 2017 to 2022
13.4.5 Venezuela Cancer Gene Therapy Consumption Volume from 2017 to 2022
13.4.6 Peru Cancer Gene Therapy Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Cancer Gene Therapy Consumption Volume from 2017 to 2022
13.4.8 Ecuador Cancer Gene Therapy Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Cancer Gene Therapy Business
14.1 Adaptimmune
14.1.1 Adaptimmune Company Profile
14.1.2 Adaptimmune Cancer Gene Therapy Product Specification
14.1.3 Adaptimmune Cancer Gene Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Bluebird bio
14.2.1 Bluebird bio Company Profile
14.2.2 Bluebird bio Cancer Gene Therapy Product Specification
14.2.3 Bluebird bio Cancer Gene Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Celgene
14.3.1 Celgene Company Profile
14.3.2 Celgene Cancer Gene Therapy Product Specification
14.3.3 Celgene Cancer Gene Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Shanghai Sunway Biotech
14.4.1 Shanghai Sunway Biotech Company Profile
14.4.2 Shanghai Sunway Biotech Cancer Gene Therapy Product Specification
14.4.3 Shanghai Sunway Biotech Cancer Gene Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Shenzhen SiBiono GeneTech
14.5.1 Shenzhen SiBiono GeneTech Company Profile
14.5.2 Shenzhen SiBiono GeneTech Cancer Gene Therapy Product Specification
14.5.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 SynerGene Therapeutics
14.6.1 SynerGene Therapeutics Company Profile
14.6.2 SynerGene Therapeutics Cancer Gene Therapy Product Specification
14.6.3 SynerGene Therapeutics Cancer Gene Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Altor BioScience
14.7.1 Altor BioScience Company Profile
14.7.2 Altor BioScience Cancer Gene Therapy Product Specification
14.7.3 Altor BioScience Cancer Gene Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Amgen
14.8.1 Amgen Company Profile
14.8.2 Amgen Cancer Gene Therapy Product Specification
14.8.3 Amgen Cancer Gene Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Argenx
14.9.1 Argenx Company Profile
14.9.2 Argenx Cancer Gene Therapy Product Specification
14.9.3 Argenx Cancer Gene Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 BioCancell
14.10.1 BioCancell Company Profile
14.10.2 BioCancell Cancer Gene Therapy Product Specification
14.10.3 BioCancell Cancer Gene Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 GlaxoSmithKline
14.11.1 GlaxoSmithKline Company Profile
14.11.2 GlaxoSmithKline Cancer Gene Therapy Product Specification
14.11.3 GlaxoSmithKline Cancer Gene Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Merck
14.12.1 Merck Company Profile
14.12.2 Merck Cancer Gene Therapy Product Specification
14.12.3 Merck Cancer Gene Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 OncoGenex Pharmaceuticals
14.13.1 OncoGenex Pharmaceuticals Company Profile
14.13.2 OncoGenex Pharmaceuticals Cancer Gene Therapy Product Specification
14.13.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.14 Transgene
14.14.1 Transgene Company Profile
14.14.2 Transgene Cancer Gene Therapy Product Specification
14.14.3 Transgene Cancer Gene Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Cancer Gene Therapy Market Forecast (2023-2028)
15.1 Global Cancer Gene Therapy Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Cancer Gene Therapy Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Cancer Gene Therapy Value and Growth Rate Forecast (2023-2028)
15.2 Global Cancer Gene Therapy Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Cancer Gene Therapy Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Cancer Gene Therapy Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Cancer Gene Therapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Cancer Gene Therapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Cancer Gene Therapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Cancer Gene Therapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Cancer Gene Therapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Cancer Gene Therapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Cancer Gene Therapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Cancer Gene Therapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Cancer Gene Therapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Cancer Gene Therapy Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Cancer Gene Therapy Consumption Forecast by Type (2023-2028)
15.3.2 Global Cancer Gene Therapy Revenue Forecast by Type (2023-2028)
15.3.3 Global Cancer Gene Therapy Price Forecast by Type (2023-2028)
15.4 Global Cancer Gene Therapy Consumption Volume Forecast by Application (2023-2028)
15.5 Cancer Gene Therapy Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
